Active Induction of a Multiple Sclerosis-Like Disease in Common Laboratory Mouse Strains

Jacqueline M Orian1, Dain L Maxwell2,3, Vernise J T Lim2

  • 1Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia. J.Orian@latrobe.edu.au.

Insights

Experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS), involves inducing neuroinflammation in rodents using CNS antigens. This study details reproducible protocols for three distinct EAE variants to aid MS research.

Area of Science:

  • Neuroimmunology
  • Experimental models of disease
  • Autoimmunity

Background:

  • Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model for studying multiple sclerosis (MS) immunopathogenesis and therapeutics.
  • EAE is induced by immunizing susceptible hosts, typically rodents, with central nervous system (CNS) antigens.
  • EAE represents a spectrum of diseases with varying clinical, immunological, and pathological features depending on host and antigen combinations.

Purpose of the Study:

  • To describe reproducible protocols for generating three specific variants of EAE.
  • To provide guidance on maintaining the unique features and reproducibility of these EAE models.
  • To facilitate preclinical evaluation of MS therapeutics using optimized EAE models.

Main Methods:

  • Active immunization of rodents with specific CNS antigens (whole homogenate, myelin proteins, or peptides).
  • Careful optimization of host/antigen combinations and experimental conditions.
  • Detailed protocol descriptions for generating and maintaining three distinct EAE variants.

Main Results:

  • Successful generation of three distinct EAE variants in the laboratory.
  • Characterization of unique clinical profiles, immunological, and pathological features for each variant.
  • Demonstration of reproducibility and methods for maintaining variant-specific characteristics.

Conclusions:

  • Optimized protocols are crucial for establishing reproducible EAE variants.
  • Specific EAE variants offer distinct models for investigating MS pathogenesis.
  • These protocols enhance the utility of EAE as a preclinical model for MS therapeutics.

Related Concept Videos